193 related articles for article (PubMed ID: 30530920)
21. Sustained protein synthesis and reduced eEF2K levels in TAp73
Rotblat B; Agostini M; Niklison-Chirou MV; Amelio I; Willis AE; Melino G
Cell Cycle; 2018; 17(23):2637-2643. PubMed ID: 30507330
[TBL] [Abstract][Full Text] [Related]
22. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
23. Targeting p73 in cancer.
Maas AM; Bretz AC; Mack E; Stiewe T
Cancer Lett; 2013 May; 332(2):229-36. PubMed ID: 21903324
[TBL] [Abstract][Full Text] [Related]
24. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
Logotheti S; Michalopoulos I; Sideridou M; Daskalos A; Kossida S; Spandidos DA; Field JK; Vojtesek B; Liloglou T; Gorgoulis V; Zoumpourlis V
FEBS J; 2010 Jul; 277(14):3014-27. PubMed ID: 20528922
[TBL] [Abstract][Full Text] [Related]
25. The interactome of the copper transporter ATP7A belongs to a network of neurodevelopmental and neurodegeneration factors.
Comstra HS; McArthy J; Rudin-Rush S; Hartwig C; Gokhale A; Zlatic SA; Blackburn JB; Werner E; Petris M; D'Souza P; Panuwet P; Barr DB; Lupashin V; Vrailas-Mortimer A; Faundez V
Elife; 2017 Mar; 6():. PubMed ID: 28355134
[TBL] [Abstract][Full Text] [Related]
26. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
27. p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression.
Landré V; Antonov A; Knight R; Melino G
Oncotarget; 2016 Mar; 7(11):11785-802. PubMed ID: 26930720
[TBL] [Abstract][Full Text] [Related]
28. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.
Shanbhag V; Jasmer-McDonald K; Zhu S; Martin AL; Gudekar N; Khan A; Ladomersky E; Singh K; Weisman GA; Petris MJ
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6836-6841. PubMed ID: 30890638
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific roles of p73 in development and homeostasis.
Nemajerova A; Moll UM
J Cell Sci; 2019 Oct; 132(19):. PubMed ID: 31582429
[TBL] [Abstract][Full Text] [Related]
31. TAp73 contributes to the oxidative stress response by regulating protein synthesis.
Marini A; Rotblat B; Sbarrato T; Niklison-Chirou MV; Knight JRP; Dudek K; Jones C; Bushell M; Knight RA; Amelio I; Willis AE; Melino G
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6219-6224. PubMed ID: 29844156
[TBL] [Abstract][Full Text] [Related]
32. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.
Leong CO; Vidnovic N; DeYoung MP; Sgroi D; Ellisen LW
J Clin Invest; 2007 May; 117(5):1370-80. PubMed ID: 17446929
[TBL] [Abstract][Full Text] [Related]
33. RIP kinase-mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin-treated bladder cancer cells.
Chung YH; Kim D
Oncol Rep; 2016 Aug; 36(2):1135-42. PubMed ID: 27349281
[TBL] [Abstract][Full Text] [Related]
34. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
[TBL] [Abstract][Full Text] [Related]
35. The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells.
Dabiri Y; Kalman S; Gürth CM; Kim JY; Mayer V; Cheng X
Sci Rep; 2017 Jul; 7(1):5423. PubMed ID: 28710427
[TBL] [Abstract][Full Text] [Related]
36. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
[TBL] [Abstract][Full Text] [Related]
37. Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.
Kasim V; Huang C; Zhang J; Jia H; Wang Y; Yang L; Miyagishi M; Wu S
Biochem Biophys Res Commun; 2014 Jul; 449(3):319-26. PubMed ID: 24845566
[TBL] [Abstract][Full Text] [Related]
38. ∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.
Caiola E; Marrazzo E; Alesci S; Broggini M; Marabese M
Tumour Biol; 2016 Feb; 37(2):2015-21. PubMed ID: 26337278
[TBL] [Abstract][Full Text] [Related]
39. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
40. The expression of mouse double minute 2 homolog and P73 had no correlation with growth arrest DNA damage-inducible gene 45α in patients with non-small-cell lung carcinoma: A STROBE-compliant study.
Wang B; Liang C; Liu H; Lin J; Wang B; Fan K; Ren Z; Wang B; Li T; Qi K; Tian X
Medicine (Baltimore); 2019 Dec; 98(51):e17944. PubMed ID: 31860949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
